A GREM1 gene variant associates with diabetic nephropathy

Journal of the American Society of Nephrology

Volumn 21, Issue 5, 2010, Pages 773-781

  McKnight, Amy Jayne ^a   Patterson, Christopher C ^a   Pettigrew, Kerry A ^a   Savage, David A ^a   Kilner, Jill ^a   Murphy, Madeline ^b   Sadlier, Denise ^b   Maxwell, Alexander P ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC SUSCEPTIBILITY; GENOTYPE; GREM1 GENE; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77952574531     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009070773     Document Type: Article

References (50)

1. McKnight AJ, O'Donoghue D, Maxwell AP: Annotated chromosome maps for renal disease. Hum Mutat 30: 314-320, 2009
2. McKnight AJ, Woodman AM, Parkkonen M, Patterson CC, Savage DA, Forsblom C, Pettigrew KA, Sadlier D, Groop PH, Maxwell AP: Investigation of DNA polymorphisms in SMAD genes for genetic predisposition to diabetic nephropathy in patients with type 1 diabetes mellitus. Diabetologia 52: 844-849, 2009
3. Wanic K, Placha G, Dunn J, Smiles A, Warram JH, Krolewski AS: Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: Results of large case-control and follow-up studies. Diabetes 57: 2547-2551, 2008
4. Hsu DR, Economides AN, Wang X, Eimon PM, Harland RM: The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol Cell 1: 673-683, 1998
5. Capdevila J, Tsukui T, Rodriquez EC, Zappavigna V, Izpisua Belmonte JC: Control of vertebrate limb outgrowth by the proximal factor Meis2 and distal antagonism of BMPs by Gremlin. Mol Cell 4: 839-849, 1999
6. Lappin DW, Hensey C, McMahon R, Godson C, Brady HR: Gremlins, glomeruli and diabetic nephropathy. Curr Opin Nephrol Hypertens 9: 469-472, 2000
7. Michos O, Panman L, Vintersten K, Beier K, Zeller R, Zuniga A: Grem- lin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis. Development 131: 3401-3410, 2004
8. Zhang Y, Zhang Q: Bone morphogenetic protein-7 and Gremlin: New emerging therapeutic targets for diabetic nephropathy. Biochem Biophys Res Commun 383: 1-3, 2009
9. Topol LZ, Marx M, Laugier D, Bogdanova NN, Boubnov NV, Clausen PA, Calothy G, Blair DG: Identification of drm, a novel gene whose expression is suppressed in transformed cells and which can inhibit growth of normal but not transformed cells in culture. Mol Cell Biol 17: 4801-4810, 1997
10. McMahon R, Murphy M, Clarkson M, Taal M, Mackenzie HS, Godson C, Martin F, Brady HR: IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factorbeta1. J Biol Chem 275: 9901-9904, 2000
11. Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F, Brady HR: Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 274: 5830-5834, 1999
12. Yanagita M: Modulator of bone morphogenetic protein activity in the progression of kidney diseases. Kidney Int 70: 989-993, 2006
13. Dolan V, Murphy M, Sadlier D, Lappin D, Doran P, Godson C, Martin F, O'Meara Y, Schmid H, Henger A, Kretzler M, Droguett A, Mezzano S, Brady HR: Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy. Am J Kidney Dis 45: 1034-1039, 2005
14. Khokha MK, Hsu D, Brunet LJ, Dionne MS, Harland RM: Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning. Nat Genet 34: 303-307, 2003
15. Wang SN, Lapage J, Hirschberg R: Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J Am Soc Nephrol 12: 2392-2399, 2001
16. Roxburgh SA, Kattla JJ, Curran SP, O'Meara YM, Pollock CA, Goldschmeding R, Godson C, Martin F, Brazil DP: Allelic depletion of grem1 attenuates diabetic kidney disease. Diabetes 8: 1641-1650, 2009
17. Walsh DW, Roxburgh SA, McGettigan P, Berthier CC, Higgins DG, Kretzler M, Cohen CD, Mezzano S, Brazil DP, Martin F: Co-regulation of Gremlin and Notch signaling in diabetic nephropathy. Biochim Biophys Acta 1782: 10-21, 2008
18. Carvajal G, Droguett A, Burgos ME, Aros C, Ardiles L, Flores C, Carpio D, Ruiz-Ortega M, Egido J, Mezzano S: Gremlin: A novel mediator of epithelial mesenchymal transition and fibrosis in chronic allograft nephropathy. Transplant Proc 40: 734-739, 2008
19. Mezzano S, Droguett A, Burgos ME, Aros C, Ardiles L, Flores C, Carpio D, Carvajal G, Ruiz-Ortega M, Egido J: Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauciimmune glomerulonephritis. Nephrol Dial Transplant 22: 1882-1890, 2007
20. Boreham C, Savage JM, Primrose D, Cran G, Strain J: Coronary risk factors in schoolchildren. Arch Dis Child 68: 182-186, 1993
21. Pesole G, Liuni S: Internet resources for the functional analysis of 5′ and 3′ untranslated regions of eukaryotic mRNAs. Trends Genet 15: 378, 1999
22. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ: miRBase: Tools for microRNA genomics. Nucleic Acids Res 36: D154-D158, 2008
23. Stenvinkel P, Karimi M, Johansson S, Axelsson J, Suliman M, Lindholm B, Heimburger O, Barany P, Alvestrand A, Nordfors L, Qureshi AR, Ekstrom TJ, Schalling M: Impact of inflammation on epigenetic DNA methylation-A novel risk factor for cardiovascular disease? J Intern Med 261: 488-499, 2007
24. Gardiner-Garden M, Frommer M: CpG islands in vertebrate genomes. J Mol Biol 196: 261-282, 1987
25. Suzuki M, Shigematsu H, Shames DS, Sunaga N, Takahashi T, Shivapurkar N, Iizasa T, Frenkel EP, Minna JD, Fujisawa T, Gazdar AF: DNA methylation- associated inactivation of TGFbeta-related genes DRM/ Gremlin, RUNX3, and HPP1 in human cancers. Br J Cancer 93: 1029-1037, 2005
26. Ezura Y, Sekiya I, Koga H, Muneta T, Noda M: Methylation status of CpG islands in the promoter regions of signature genes during chondrogenesis of human synovium-derived mesenchymal stem cells. Arthritis Rheum 60: 1416-1426, 2009
27. Lai EC: Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 30: 363-364, 2002
28. Mertens PR, Raffetseder U, Rauen T: Notch receptors: A new target in glomerular diseases. Nephrol Dial Transplant 23: 2743-2745, 2008
29. Niranjan T, Bielesz B, Gruenwald A, Ponda MP, Kopp JB, Thomas DB, Susztak K: The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med 14: 290-298, 2008
30. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004
31. Topol LZ, Modi WS, Koochekpour S, Blair DG: DRM/GREMLIN (CKTSF1B1) maps to human chromosome 15 and is highly expressed in adult and fetal brain. Cytogenet Cell Genet 89: 79-84, 2000
32. The International HapMap consortium: A second generation human haplotype map of over 3.1 million SNPs. Nature 449: 851-861, 2007
33. Hills T, Todd P: Population heterogeneity and individual differences in an assortative agent-based marriage and divorce model (MADAM) using search with relaxing expectations. JASSS 11: 5, 2008
34. Covic AM, Iyengar SK, Olson JM, Sehgal AR, Constantiner M, Jedrey C, Kara M, Sabbagh E, Sedor JR, Schelling JR: A family-based strategy to identify genes for diabetic nephropathy. Am J Kidney Dis 37: 638-647, 2001
35. Thameem F, Puppala S, He X, Arar NH, Stern MP, Blangero J, Duggirala R, Abboud HE: Evaluation of gremlin 1 (GREM1) as a candidate susceptibility gene for albuminuria-related traits in Mexican Americans with type 2 diabetes mellitus. Metabolism 58: 1496-1502, 2009
36. Zuniga A, Michos O, Spitz F, Haramis AP, Panman L, Galli A, Vintersten K, Klasen C, Mansfield W, Kuc S, Duboule D, Dono R, Zeller R: Mouse limb deformity mutations disrupt a global control region within the large regulatory landscape required for Gremlin expression. Genes Dev 18: 1553-1564, 2004
37. Lettice LA, Horikoshi T, Heaney SJ, van Baren MJ, van der Linde HC, Breedveld GJ, Joosse M, Akarsu N, Oostra BA, Endo N, Shibata M, Suzuki M, Takahashi E, Shinka T, Nakahori Y, Ayusawa D, Nakabayashi K, Scherer SW, Heutink P, Hill RE, Noji S: Disruption of a long-range cis-acting regulator for Shh causes preaxial polydactyly. Proc Natl Acad Sci U S A 99: 7548-7553, 2002
38. Wynshaw-Boris A, Ryan G, Deng CX, Chan DC, Jackson-Grusby L, Larson D, Dunmore JH, Leder P: The role of a single formin isoform in the limb and renal phenotypes of limb deformity. Mol Med 3: 372-384, 1997
39. Schneider M, Lane L, Boutet E, Lieberherr D, Tognolli M, Bougueleret L, Bairoch A: The UniProtKB/Swiss-Prot knowledgebase and its Plant Proteome Annotation Program. J Proteomics 72: 567-573, 2009
40. Namkoong H, Shin SM, Kim HK, Ha SA, Cho GW, Hur SY, Kim TE, Kim JW: The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein. BMC Cancer 6: 74, 2006
41. McKnight AJ, Maxwell AP, Fogarty DG, Sadlier D Savage DA and The Warren 3/UK GoKinD Study Group: Genetic analysis of coronary artery disease single nucleotide polymorphisms in diabetic nephropathy. Nephrol Dial Transplant 24: 2473-2476, 2009
42. McKnight AJ, Maxwell AP, Patterson CC, Brady HR, Savage DA: Association of VEGF-1499C>T polymorphism with diabetic nephropathy in type 1 diabetes mellitus. J Diabetes Complicat 21: 242-245, 2007
43. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Wheeler DL: GenBank. Nucleic Acids Res 36: D25-D30, 2008
44. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K: dbSNP: The NCBI database of genetic variation. Nucleic Acids Res 29: 308-311, 2001
45. SNPHAP: A Program for Estimating Frequencies of Large Haplotypes of SNPs. Available online at http://www-gene.cimr.cam.ac.uk/clayton/software. Accessed July 21, 2009
46. Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G, Ueda H, Cordell HJ, Eaves IA, Dudbridge F, Twells RC, Payne F, Hughes W, Nutland S, Stevens H, Carr P, Tuomilehto-Wolf E, Tuomilehto J, Gough SC, Clayton DG, Todd JA: Haplotype tagging for the identification of common disease genes. Nat Genet 29: 233-237, 2001
47. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265, 2005
48. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC: PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575, 2007
49. Clayton DG: Population association. In: Handbook of Statistical Genetics, edited by Balding DJ, Bishop M, Canning C, Chichester, United Kingdom, John Wiley & Sons, 2001
50. Spielman RS, McGinnis RE, Ewens WJ: Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52: 506-516, 1993